期刊文献+

甲状腺癌中肿瘤坏死因子相关凋亡诱导配体及其受体的表达 被引量:3

EXPRESSION OF TRAIL AND TRAILR IN THYROID CARCINOMA
下载PDF
导出
摘要 目的 研究肿瘤坏死因子相关凋亡诱导配体 (TRAIL)和肿瘤坏死因子相关凋亡诱导配体受体(TRAILR)在甲状腺癌中的表达及意义。 方法 采用免疫组织化学方法 ,检测 5例正常甲状腺、13例乳头状甲状腺癌、3例滤泡状甲状腺癌和 12例甲状腺癌旁组织中TRAIL和TRAILR的表达和分布。 结果 乳头状、滤泡状甲状腺癌组织和正常甲状腺组织中的甲状腺滤泡细胞均表达TRAIL和全部的TRAILR ,其中诱捕受体TRAILR4在正常甲状腺组织和甲状腺癌旁组织表达较弱。 结论 甲状腺癌组织中的甲状腺滤泡细胞表达TRAIL和全部的TRAILR ,提示癌变的甲状腺滤泡细胞通过自身表达TRAIL ,以自分泌或旁分泌的形式和其死亡受体TRAILR1、TRAILR2结合 ,诱导癌变的甲状腺滤泡细胞发生凋亡 ,诱捕受体TRAILR3。 Objective To investigate the expression of TNF-related apoptosis-inducing ligand(TRAIL) and TNF-related apoptosis-inducing ligand receptor(TRAILR) in thyroid carcinoma. Methods Expression and distribution of TRAIL and TRAILR in thyroid tissues from 13 patients with papillary thyroid carcinoma, 3 patients with follicular thyroid carcinoma and 5 normal necrospy subjects were studied by immunohistochemical methods. Results TRAIL and all of TRAILR immunoreactivity was observed in both thyroid tissues from papillary thyroid carcinoma and follicular thyroid carcinoma. TRAILR4 was expressed highly in all thyroid carcinoma tissues but weakly in normal thyroid tissues.Conclusion TRAIL and all of TRAILR were present in thyroid tissues of papillary thyroid carcinoma and follicular thyroid carcinoma. Expression of TRAIL, TRAILR1 and TRAILR2 by thyrocytes in thyroid carcinoma may induce their apoptosis through autocrine or paracrine. Thyroid carcinoma cells were sensitive to TRAIL-inducing apoptosis despite expression of both decoy receptors. [
出处 《解剖学报》 CAS CSCD 北大核心 2002年第4期434-437,共4页 Acta Anatomica Sinica
  • 相关文献

参考文献6

  • 1[1]Griffith T, Brunner T, Fletcher S, et al. Fas ligand-induced apoptosis as a mechanism of immune privilige [J]. Science, 1995,270(5239):1189-1192.
  • 2[2]Pitti R, Masters S, Ruppert S, et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family [J]. J Biol Chem, 1996,271(22):12687-12690.
  • 3[3]Pan G, Ni G, Wei YF, et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL [J]. Science, 1997,277(5327):815-818.
  • 4[4]Mitsiades N, Poulaki V, Sophia T, et al. Thyroid carcinoma cells are resistant to Fas-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand [J]. Cancer Res, 2000,60(15):4122-4129.
  • 5[5]Griffith T, Chin W Jackson G, et al. Intracelluar regulation of TRAIL-induced apoptosis in human melanoma cell [J]. J Immunol, 1998,161(6):2833-2840.
  • 6[6]Keane M, Ettenberg S, Russell E, et al. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines [J]. Cancer Res, 1999,59(3):734-741.

同被引文献25

  • 1马远方,张军,赵粤萍,杨东亮,陈有海.肿瘤细胞对TRAIL敏感性与其表面DR5表达水平的相关性研究[J].中华肿瘤杂志,2004,26(9):528-530. 被引量:32
  • 2刘广超,马远方,张军,李淑莲,卢峰,白慧玲,赵粤萍.抗人DR5抗体mDRA-6细胞毒作用机制分析[J].细胞与分子免疫学杂志,2006,22(6):790-793. 被引量:7
  • 3Wiley SR,Schooley K,Smolak PJ,et al.Identification and characterization of a new member of the TNF family that induces apoptosis[J].Immunity,1995,3(6):673-682.
  • 4Abdulghani J,El-Deiry WS.TRAIL receptor signaling and therapeutics[J].Expert Opin Ther Targets,2010,14(10):1091-1108.
  • 5Bai X,Williams JL,Greenwood SL,et al.A placental protective role for trophoblast-derived TNF-related apoptosis-inducing ligand (TRAIL)[J].Placenta,2009,30(10):855-860.
  • 6Bellail AC,Qi L,Mulligan P,et al.TRAIL agonists on clinical trials for cancer therapy:the promises and the challenges[J].Rev Recent Clin Trials,2009,4(1):34-41.
  • 7Zhang Y,Zhang B.TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5[J].Mol Cancer Res,2008,6(12):1861-1871.
  • 8Rao MS,Shetty AK.Efficacy of doublecortin as a marker to analyse the absolute number and dendritic growth of newly generated neurons in the adult dentate gyrus[J].Eur J Neurosci,2004,9(2):234-246.
  • 9Thoolen B.BrdU labeling of S-phase cells in testes and small intestine of mice,using microwave irradiation for immunogold-silver staining:an immunocytochemical study[J].J Histochem Cytochem,1990,38(2):267-273.
  • 10Belyanskaya LL,Ziogas A,Hopkins-Donaldson S,et al.TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8[J].Lung Cancerm,2008,60(3):355-365.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部